Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Clin Chem Retrieve available abstracts of 78 articles: HTML format Text format

Single Articles

June 2018
1. MYHRE PL, Omland T, Sarvari SI, Ukkonen H, et al
   Cardiac Troponin T Concentrations, Reversible Myocardial Ischemia, and Indices of Left Ventricular Remodeling in Patients with Suspected Stable Angina Pectoris: a DOPPLER-CIP Substudy.
   Clin Chem. 2018 Jun 29. pii: clinchem.2018.288894.
   PubMed     Text format     Abstract available
   
   
   
2. BOEDDINGHAUS J, Twerenbold R, Nestelberger T, Badertscher P, et al
   Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction.
   Clin Chem. 2018 Jun 25. pii: clinchem.2018.286906.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. KIMENAI DM, Janssen EBNJ, Eggers KM, Lindahl B, et al
   Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review.
   Clin Chem. 2018 May 29. pii: clinchem.2018.286781.
   PubMed     Text format     Abstract available
   
   
   
4. THAN MP, Aldous SJ, Troughton RW, Pemberton CJ, et al
   Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study.
   Clin Chem. 2018 May 14. pii: clinchem.2017.285700.
   PubMed     Text format     Abstract available
   
   
   April 2018
5. KATRUKHA IA, Kogan AE, Vylegzhanina AV, Kharitonov AV, et al
   Full-Size Cardiac Troponin I and Its Proteolytic Fragments in Blood of Patients with Acute Myocardial Infarction: Antibody Selection for Assay Development.
   Clin Chem. 2018 Apr 9. pii: clinchem.2017.286211.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. GREENSLADE J, Cho E, Van Hise C, Hawkins T, et al
   Evaluating Rapid Rule-out of Acute Myocardial Infarction by Use of a High-Sensitivity Cardiac Troponin I Assay at Presentation.
   Clin Chem. 2018 Feb 1. pii: clinchem.2017.283887.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. BADERTSCHER P, Boeddinghaus J, Nestelberger T, Twerenbold R, et al
   Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin.
   Clin Chem. 2018 Jan 17. pii: clinchem.2017.279513.
   PubMed     Text format     Abstract available
   
   
   
8. WU AHB, Christenson RH, Greene DN, Jaffe AS, et al
   Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Mark
   Clin Chem. 2018 Jan 17. pii: clinchem.2017.277186.
   PubMed     Text format     Abstract available
   
   
   December 2017
9. BHUPATHIRAJU SN, Stampfer MJ
   Menopausal Hormone Therapy and Cardiovascular Disease: Unraveling the Role of Age and Time Since Menopause Onset.
   Clin Chem. 2017 Dec 8. pii: clinchem.2017.272823.
   PubMed     Text format    
   
   
   October 2017
10. WALTER JE, Honegger U, Puelacher C, Mueller D, et al
    Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease.
    Clin Chem. 2017 Oct 16. pii: clinchem.2017.277210.
    PubMed     Text format     Abstract available
    
    
    
11. VARBO A, Freiberg JJ, Nordestgaard BG
    Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study.
    Clin Chem. 2017 Oct 11. pii: clinchem.2017.279463.
    PubMed     Text format     Abstract available
    
    
    
12. SILBERNAGEL G, Pagel P, Pfahlert V, Genser B, et al
    High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality.
    Clin Chem. 2017 Oct 11. pii: clinchem.2017.275636.
    PubMed     Text format     Abstract available
    
    
    
13. MARRA MP, Zaninotto M, Cacciavillani L, Iliceto S, et al
    Massive Troponin Release and Normal Coronary Arteries: Where Does the Truth Lie?
    Clin Chem. 2017;63:1570-1573.
    PubMed     Text format    
    
    
    September 2017
14. KOENIG W
    C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS?
    Clin Chem. 2017 Sep 20. pii: clinchem.2017.273243.
    PubMed     Text format    
    
    
    
15. CAO J, Steffen BT, Guan W, Budoff M, et al
    Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis.
    Clin Chem. 2017 Sep 13. pii: clinchem.2016.270751.
    PubMed     Text format     Abstract available
    
    
    
16. JAGODZINSKI A, Neumann JT, Ojeda F, Sorensen NA, et al
    Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment-Results from the Randomized TEAMSTA Protect I Trial.
    Clin Chem. 2017 Sep 13. pii: clinchem.2017.275289.
    PubMed     Text format     Abstract available
    
    
    
17. EGGERS KM, Lindahl B
    Impact of Sex on Cardiac Troponin Concentrations-A Critical Appraisal.
    Clin Chem. 2017;63:1457-1464.
    PubMed     Text format     Abstract available
    
    
    July 2017
18. SANDOVAL Y, Smith SW, Thordsen SE, Bruen CA, et al
    Diagnostic Performance of High Sensitivity Compared with Contemporary Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction.
    Clin Chem. 2017 Jul 12. pii: clinchem.2017.272930.
    PubMed     Text format     Abstract available
    
    
    June 2017
19. KATUS HA, Giannitsis E
    Prognostic Value of Serum Troponin T in Unstable Angina.
    Clin Chem. 2017 Jun 23. pii: clinchem.2017.272799.
    PubMed     Text format    
    
    
    
20. EGGERS KM, Lindahl B, Carrero JJ, Evans M, et al
    Cardiac Troponins and Their Prognostic Importance in Patients with Suspected Acute Coronary Syndrome and Renal Dysfunction.
    Clin Chem. 2017 Jun 14. pii: clinchem.2017.271890.
    PubMed     Text format     Abstract available
    
    
    
21. KATRUKHA IA, Kogan AE, Vylegzhanina AV, Serebryakova MV, et al
    Thrombin-Mediated Degradation of Human Cardiac Troponin T.
    Clin Chem. 2017;63:1094-1100.
    PubMed     Text format     Abstract available
    
    
    May 2017
22. WILDI K, Cullen L, Twerenbold R, Greenslade JH, et al
    Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h Algorithm.
    Clin Chem. 2017 May 17. pii: clinchem.2016.268359.
    PubMed     Text format     Abstract available
    
    
    
23. CHAN M, Neely ML, Roe MT, Goodman SG, et al
    Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Clin Chem. 2017 May 17. pii: clinchem.2016.265272.
    PubMed     Text format     Abstract available
    
    
    
24. EGGERS KM
    Serial Measurement of Biomarkers after Acute Coronary Syndrome: Which One to Choose?
    Clin Chem. 2017 May 17. pii: clinchem.2017.273789.
    PubMed     Text format    
    
    
    
25. DUPREZ DA, Gross MD, Sanchez OA, Kizer JR, et al
    Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
    Clin Chem. 2017 May 17. pii: clinchem.2016.270520.
    PubMed     Text format     Abstract available
    
    
    
26. MARJOT J, Kaier TE, Martin ED, Reji SS, et al
    Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium.
    Clin Chem. 2017;63:990-996.
    PubMed     Text format     Abstract available
    
    
    April 2017
27. KAVSAK PA, Clark L, Jaffe AS
    Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-Hour Algorithms for Early Rule-Out and Rule-In for Myocardial Infarction.
    Clin Chem. 2017 Apr 20. pii: clinchem.2017.272914.
    PubMed     Text format    
    
    
    
28. LAWLER PR, Akinkuolie AO, Ridker PM, Sniderman AD, et al
    Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women.
    Clin Chem. 2017;63:870-879.
    PubMed     Text format     Abstract available
    
    
    March 2017
29. DIEPLINGER B, Bocksrucker C, Egger M, Eggers C, et al
    Prognostic Value of Inflammatory and Cardiovascular Biomarkers for Prediction of 90-Day All-Cause Mortality after Acute Ischemic Stroke-Results from the Linz Stroke Unit Study.
    Clin Chem. 2017 Mar 27. pii: clinchem.2016.269969.
    PubMed     Text format     Abstract available
    
    
    
30. CLERICO A, Passino C
    Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction.
    Clin Chem. 2017 Mar 20. pii: clinchem.2016.269522.
    PubMed     Text format    
    
    
    February 2017
31. LYON AW, Kavsak PA, Lyon OA, Worster A, et al
    Simulation Models of Misclassification Error for Single Thresholds of High-Sensitivity Cardiac Troponin I Due to Assay Bias and Imprecision.
    Clin Chem. 2017;63:585-592.
    PubMed     Text format     Abstract available
    
    
    January 2017
32. MINGELS AM, Cardinaels EP, Broers NJ, van Sleeuwen A, et al
    Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.
    Clin Chem. 2017 Jan 10. pii: clinchem.2016.261644.
    PubMed     Text format     Abstract available
    
    
    
33. BREITLING LP, Mons U, Hahmann H, Koenig W, et al
    The Longer, the Better? An Empirical Study of the Extent and Mechanisms of Attenuating Biomarker Associations in Cardiovascular Patient Cohorts.
    Clin Chem. 2017 Jan 10. pii: clinchem.2016.263202.
    PubMed     Text format     Abstract available
    
    
    
34. BODOR GS
    Does This Patient Have Acute Myocardial Infarction?
    Clin Chem. 2017;63:439-440.
    PubMed     Text format    
    
    
    
35. SUZUKI T, Heaney LM, Jones DJ, Ng LL, et al
    Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.
    Clin Chem. 2017;63:420-428.
    PubMed     Text format     Abstract available
    
    
    
36. SHORTT C, Ma J, Clayton N, Sherbino J, et al
    Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome.
    Clin Chem. 2017;63:403-414.
    PubMed     Text format     Abstract available
    
    
    
37. PRICKETT TC, Doughty RN, Troughton RW, Frampton CM, et al
    C-Type Natriuretic Peptides in Coronary Disease.
    Clin Chem. 2017;63:316-324.
    PubMed     Text format     Abstract available
    
    
    
38. CULLEN LA, Mills NL, Mahler S, Body R, et al
    Early Rule-Out and Rule-In Strategies for Myocardial Infarction.
    Clin Chem. 2017;63:129-139.
    PubMed     Text format     Abstract available
    
    
    
39. SANDOVAL Y, Thygesen K
    Myocardial Infarction Type 2 and Myocardial Injury.
    Clin Chem. 2017;63:101-107.
    PubMed     Text format     Abstract available
    
    
    
40. TRICOCI P
    Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.
    Clin Chem. 2017;63:82-90.
    PubMed     Text format     Abstract available
    
    
    
41. HUGHES MF, Ojeda F, Saarela O, Jorgensen T, et al
    Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study.
    Clin Chem. 2017;63:334-342.
    PubMed     Text format     Abstract available
    
    
    
42. ABBASI A, Kieneker LM, Corpeleijn E, Gansevoort RT, et al
    Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.
    Clin Chem. 2017;63:278-287.
    PubMed     Text format     Abstract available
    
    
    
43. EGGERS KM, Lindahl B
    Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome.
    Clin Chem. 2017;63:223-235.
    PubMed     Text format     Abstract available
    
    
    
44. WOLLERT KC, Kempf T, Wallentin L
    Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.
    Clin Chem. 2017;63:140-151.
    PubMed     Text format     Abstract available
    
    
    
45. MAHLEY RW
    Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases.
    Clin Chem. 2017;63:14-20.
    PubMed     Text format    
    
    
    
46. APPLE FS, Cullen L, Felker GM, Ginsburg G, et al
    Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.
    Clin Chem. 2017;63:1-4.
    PubMed     Text format    
    
    
    
47. EISEN A, Bonaca MP, Jarolim P, Scirica BM, et al
    High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2 degrees P - TIMI 50 Trial.
    Clin Chem. 2017;63:307-315.
    PubMed     Text format     Abstract available
    
    
    
48. APPLE FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J, et al
    Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care.
    Clin Chem. 2017;63:73-81.
    PubMed     Text format     Abstract available
    
    
    
49. VYLEGZHANINA AV, Kogan AE, Katrukha IA, Antipova OV, et al
    Anti-Cardiac Troponin Autoantibodies Are Specific to the Conformational Epitopes Formed by Cardiac Troponin I and Troponin T in the Ternary Troponin Complex.
    Clin Chem. 2017;63:343-350.
    PubMed     Text format     Abstract available
    
    
    
50. SANDOVAL Y, Smith SW, Shah AS, Anand A, et al
    Rapid Rule-Out of Acute Myocardial Injury Using a Single High-Sensitivity Cardiac Troponin I Measurement.
    Clin Chem. 2017;63:369-376.
    PubMed     Text format     Abstract available
    
    
    December 2016
51. WU Z, Huang Z, Jin W, Rimm EB, et al
    Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
    Clin Chem. 2016 Dec 28. pii: clinchem.2016.260828.
    PubMed     Text format     Abstract available
    
    
    
52. KVISVIK B, Morkrid L, Rosjo H, Cvancarova M, et al
    High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis.
    Clin Chem. 2016 Dec 14. pii: clinchem.2016.261107.
    PubMed     Text format     Abstract available
    
    
    
53. STRENG AS, de Boer D, van Doorn WP, Bouwman FG, et al
    Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction.
    Clin Chem. 2016 Dec 9. pii: clinchem.2016.261511.
    PubMed     Text format     Abstract available
    
    
    
54. CAPPELLETTI P, Morandini M, Moretti M, Malloggi L, et al
    How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction? The Italian Experience.
    Clin Chem. 2016 Dec 9. pii: clinchem.2016.266429.
    PubMed     Text format    
    
    
    
55. MUELLER-HENNESSEN M, Mueller C, Giannitsis E, Biener M, et al
    Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.
    Clin Chem. 2016 Dec 8. pii: clinchem.2016.258392.
    PubMed     Text format     Abstract available
    
    
    
56. LINDHOLM D, James SK, Bertilsson M, Becker RC, et al
    Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Clin Chem. 2016 Dec 8. pii: clinchem.2016.261271.
    PubMed     Text format     Abstract available
    
    
    November 2016
57. NEUMANN JT, Sorensen NA, Ojeda F, Schwemer T, et al
    Immediate Rule-out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I.
    Clin Chem. 2016 Nov 30. pii: clinchem.2016.262659.
    PubMed     Text format     Abstract available
    
    
    
58. EVERETT BM, Ridker PM
    Biomarkers for Cardiovascular Screening: Progress or Passe?
    Clin Chem. 2016 Nov 30. pii: clinchem.2016.254854.
    PubMed     Text format    
    
    
    
59. NEWBY LK
    Reconciling Systems for Acute Myocardial Infarction Definition and Coding Classification.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.266999.
    PubMed     Text format    
    
    
    
60. TUNIS SR, Messner DA
    Payer Perspectives on Coverage of Biomarker Testing in Cardiovascular Disease.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.268136.
    PubMed     Text format    
    
    
    
61. FRIEDE K, Li J, Voora D
    Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.255232.
    PubMed     Text format     Abstract available
    
    
    
62. OMLAND T, White HD
    State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.
    Clin Chem. 2016 Nov 4. pii: clinchem.2016.255190.
    PubMed     Text format     Abstract available
    
    
    
63. SMALL AM, Mehta NN, Rader DJ
    The Role of Emerging Biomarkers in Unraveling the Complex Biology Underlying Associations between HDL Cholesterol and Cardiovascular Diseases.
    Clin Chem. 2016 Nov 4. pii: clinchem.2016.267922.
    PubMed     Text format    
    
    
    
64. DIAZ-GARZON J, Sandoval Y, Smith SW, Love S, et al
    Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.263764.
    PubMed     Text format     Abstract available
    
    
    
65. SHORTT C, Xie F, Whitlock R, Ma J, et al
    Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.261776.
    PubMed     Text format     Abstract available
    
    
    
66. OHMAN EM
    Redefining the Gold Standard of Myocardial Infarction Using Troponin T.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.267047.
    PubMed     Text format    
    
    
    
67. HAGSTROM E, Held C, Stewart RA, Aylward PE, et al
    Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.260570.
    PubMed     Text format     Abstract available
    
    
    
68. MCGARRAH RW, Kelly JP, Craig DM, Haynes C, et al
    A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.261636.
    PubMed     Text format     Abstract available
    
    
    
69. DEFILIPPI CR, Herzog CA
    Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.254748.
    PubMed     Text format     Abstract available
    
    
    October 2016
70. KLINKENBERG LJ, Wildi K, van der Linden N, Kouw IW, et al
    Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction.
    Clin Chem. 2016 Oct 5. pii: clinchem.2016.257485.
    PubMed     Text format     Abstract available
    
    
    August 2016
71. JANSEN H, Koenig W, Jaensch A, Mons U, et al
    Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
    Clin Chem. 2016 Aug 18. pii: clinchem.2016.257550.
    PubMed     Text format     Abstract available
    
    
    July 2016
72. COLLINSON P, Hammerer-Lercher A, Suvisaari J, Apple FS, et al
    How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).
    Clin Chem. 2016 Jul 26. pii: clinchem.2016.259515.
    PubMed     Text format     Abstract available
    
    
    
73. LAWLER PR, Everett BM
    Assessing the Effects of Diet and Behavior on Cardiovascular Disease: The Role of Biomarkers in Understanding Biology and Mechanism.
    Clin Chem. 2016 Jul 18. pii: clinchem.2016.260448.
    PubMed     Text format    
    
    
    June 2016
74. KAIER TE, Anand A, Shah AS, Mills NL, et al
    Temporal Relationship between Cardiac Myosin Binding Protein C and Cardiac Troponin I in Type 1 Myocardial Infarction.
    Clin Chem. 2016 Jun 20. pii: clinchem.2016.257188.
    PubMed     Text format    
    
    
    
75. SCHELLER MADRID A, Rode L, Nordestgaard BG, Bojesen SE, et al
    Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals.
    Clin Chem. 2016 Jun 3. pii: clinchem.2016.258566.
    PubMed     Text format     Abstract available
    
    
    May 2016
76. DALLMEIER D, Brenner H, Mons U, Rottbauer W, et al
    Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
    Clin Chem. 2016 May 19. pii: clinchem.2016.254755.
    PubMed     Text format     Abstract available
    
    
    
77. DUPREZ DA, Otvos J, Sanchez OA, Mackey RH, et al
    Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events.
    Clin Chem. 2016 May 12. pii: clinchem.2016.255828.
    PubMed     Text format     Abstract available
    
    
    February 2016
78. STANCEL N, Chen CC, Ke LY, Chu CS, et al
    Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Clin Chem. 2016;62:320-7.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: